LATONA LENARD: Open Payments
NPI 1396457875 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 31 payments from 8 companies in 2025. Trend: 2023 $132 · 2024 $548 · 2025 $873
Food & beverage: $873
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $318 |
| Axsome Therapeutics, Inc. | 2 | $123 |
| Vanda Pharmaceuticals Inc. | 3 | $97 |
| ABBVIE INC. | 4 | $87 |
| Merck Sharp & Dohme LLC | 3 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $84 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: ARISTADA, LYBALVI, Auvelity, FANAPT, VRAYLAR, PIFELTRO, CAPLYTA, REXULTI.
Industry payments across LA — which companies pay providers there.
